China Next-Generation-Sequencing for Non-Invasive Prenatal Testing (NGS-NIPT) Market Report 2016 - Research and Markets
DUBLIN, August 22, 2016 /PRNewswire/ --
Research and Markets has announced the addition of the "Next-Generation-Sequencing for Non-Invasive Prenatal Testing (NGS-NIPT) in China" report to their offering.
Next Generation NIPT Sequencing in China estimates the market for Non Invasive Prenatal Testing in this emerging market, and generally examines the role of next generation sequencing in the company.
As part of its market analysis this report includes:
- Market for Non-Invasive Prenatal Testing using Sequencing in China
- Forecast to 2020
- Market Share
- Institutions Performing NGS
- Key Equipment Manufactuers and Service Providers
- Chinese NGS Company Profiles
Key Topics Covered:
Chapter One: Executive Summary
Chapter Two: Introduction
- China in Perspective
- Population Trends and Demographics
- Aging of Population
- Growing Chinese Hospital Sector
- Number of Hospitals in China, 2004-2015
- Hospitals in China by Class (Class I, Class II, Class III)
- Resource Constraints in Hospitals
- Intellectual Property Issues
- Higher Out of Pocket Spending in China
- Percent of Spending Out of Pocket: China vs. Other Nations
- Healthcare Reform
- Disease Costs
- Sequencing Introduction
- Sanger
- Next Generation Sequencing
- Sequencing in China
- Products Approved
- Institutions Performing NGS in China
- Technologies Used for Newborn Screening
- Traditional Tests
- Sequencing
Chapter Three: Market Analysis
- Relevant Demographics
- Hospital Use of NGS
- Hospitals Using NGS: Outsourced vs. In-House
Major Competitors Leading Companies in Next Generation Sequencing in China (Equipment Providers, Test Makers, Service Providers)
- Annoroad
- Amoy Diagnostics Co., LTD
- Berry Genomics Co. Ltd
- Beijing Genomics Institute (BGI)
- CapitalBio Corporation
- Novogene
- Daan Gene Co., Ltd.
- Shanghai Kehua Bio-engineering
- Zhejiang Dian Diagnostics
- Wuxi AppTec Co. LTD.
For more information about this report visit http://www.researchandmarkets.com/research/gcccj4/nextgenerationse
Related Topics: Women's Health, Molecular Diagnostics
Media Contact:
Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
SOURCE Research and Markets
Share this article